PRO-Melanomae. The use of PRO-CTCAE in patients receiving immunotherapy for the treatment of malignant melanoma

Dieperink, K. B. (Supervisor)

Activity: Examination and external supervisionExternal supervisor activities

Period1. Sep 20162018
ExamineeLærke Kjær Tolstrup
Examination held atUniversity of Southern Denmark